MFDS — authorised 1 August 2014
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Status: likely_approved
MFDS authorised Jardiance on 1 August 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 1 August 2014.
BOEHRINGER INGELHEIM holds the South Korean marketing authorisation.